BIO-key: 3 Key Takeaways for Long-Term Investors
The pending $1.2 million in license renewals due in early 2027 will show whether the company's software pivot can turn profitable on schedule.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.